Coocooburra, If they didn't have Dr. BP's suite
Post# of 151792
(Total Views: 622)
Posted On: 04/12/2020 1:25:47 PM
Re: Coocooburra #27055
Coocooburra,
Yes Sir !!!.
The beauty and poetic sarcasm if this does not end up in an approval is that we (CYDY and IncelLDx) where MEASURING the response of the first patients very carefully (base line, 3, days 7 days).
The counts of Lymphocytes and other blood-work paremeters are there in exquisite (and embarrassing) detail and the patients responses also present and willing to tell the tale (talk to the doctors please !!!).
Can FDA just ignore them ???. Can FDA say that several miracles took place and the T-cell count changes are a fluke ?? Or, not good enough ??. Or, what happened (and keep happening) in several cases maybe will not repeat with some other patients ???.
The possibility of successive unlikely outcomes is ... well, VERY unlikely.
So, FDA, please look at the evidence and stop the carnage now.. Time is of the essence.
Quote:
If they didn't have Dr. BP's suite of assays I would say requesting emergency approval is a waste of time. But with this combination they have a chance.
Yes Sir !!!.
The beauty and poetic sarcasm if this does not end up in an approval is that we (CYDY and IncelLDx) where MEASURING the response of the first patients very carefully (base line, 3, days 7 days).
The counts of Lymphocytes and other blood-work paremeters are there in exquisite (and embarrassing) detail and the patients responses also present and willing to tell the tale (talk to the doctors please !!!).
Can FDA just ignore them ???. Can FDA say that several miracles took place and the T-cell count changes are a fluke ?? Or, not good enough ??. Or, what happened (and keep happening) in several cases maybe will not repeat with some other patients ???.
The possibility of successive unlikely outcomes is ... well, VERY unlikely.
So, FDA, please look at the evidence and stop the carnage now.. Time is of the essence.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼